Advertising conglomerate Publicis Health LLC, a subpart of French media company Publicis Groupe SA, recently consented to a $350 million settlement regarding lawsuits brought by all 50 US states in connection with its participation in fanning the opioid epidemic. The main accusation was that the company boosted the sales of OxyContin and other highly addictive opioid painkillers, through their long-running advertising campaign for Purdue Pharma LP. Bloomberg Law reports that this campaign lasted nearly a decade.
New York Attorney General Letitia James released a statement accusing Publicis of implementing a Purdue marketing strategy to manipulate doctors. This was allegedly done to encourage them to prescribe OxyContin in greater doses and for extended periods, creating a greater dependency for patients on the drug. Notably, as part of the settlement, Publicis has agreed not to participate in the painkiller market again.
More details and context can be found in the original report. It is clear that these legal developments will have far-reaching professional and ethical implications for advertising and marketing businesses, particularly those operating within the healthcare and pharmaceutical sectors.